pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    standardized mite (Dermatophagoides pteronyssinus + Dermatophagoides farinae) allergen extract
    Odactra
    Allergic Rhino-Conjunctivitis ALK-Abello Inc
  • Marketed
    standardized short ragweed pollen (Ambrosia artemisiifolia) allergen extract
    Short Ragweed Pollen Allergenic Extract
    Allergic Rhinitis Jubilant HollisterStier LLC
  • Marketed
    streptomycin sulfate
    Streptomycin Sulfate
    Bacteremia X-GEN Pharmaceuticals DJB Inc
← prev
page 219 of 231
next →
Pain89
Neurology1
  • Marketed
    succimer
    Chemet (succimer)
    Lead Poisoning Recordati Rare Diseases Inc
  • Marketed
    succinylcholine chloride
    Succinylcholine Chloride
    General Anesthetic Effect Nordic Pharma Inc
  • Marketed
    sugammadex sodium
    Sugammadex Sodium
    Anesthetic Effect B. Braun Medical Inc
  • Phase 2
    sugemalimab
    Cejemly (sugemalimab [INN])
    Natural Killer Cell Lymphomas CStone Pharmaceuticals Co Ltd
  • Marketed
    sulconazole nitrate
    Exelderm (sulconazole nitrate)
    Tinea Corporis$DERM Journey Medical Corp
  • Marketed
    sulfadiazine
    Sulfadiazine
    Otitis Media Epic Pharma LLC
  • Marketed
    sulfisoxazole
    Sulfisoxazole
    Bacterial (Pyogenic) Meningitis Roxane Laboratories Inc
  • Marketed
    sulindac
    Sulindac
    Acute and Sub-Acute Bursitis Epic Pharma LLC
  • Marketed
    sumatriptan
    Sumatriptan (sumatriptan [INN])
    Migraine Florida Pharmaceutical Products LLC
  • pre_registration
    sumecigrel
    sumecigrel
    Acute Coronary Syndrome Jiangsu Vcare PharmaTech Co Ltd
  • Marketed
    sunitinib malate
    Sunitinib Malate
    Gastrointestinal Stromal Tumor (GIST) Wanbang Biopharmaceuticals Co Ltd
  • Phase 2
    sunobinop tosylate
    sunobinop tosylate
    Alcohol Use Disorder (AUD) Imbrium Therapeutics LP
  • Marketed
    sunvozertinib
    Zegfrovy (sunvozertinib)
    Non-Small Cell Lung Cancer Dizal Pharmaceutical Co Ltd
  • Phase 3
    surabgene lomparvovec
    surabgene lomparvovec
    Wet (Neovascular / Exudative) Macular Degeneration$ABBV AbbVie Inc.
  • Phase 2
    suratadenoturev
    Telomelysin (suratadenoturev)
    Adenocarcinoma Of The Gastroesophageal Junction Oncolys BioPharma Inc
  • Phase 1
    surlorian fumarate
    surlorian fumarate
    Unspecified Musculoskeletal Disorders RyCarma Therapeutics Inc
  • Phase 2
    surovatamig
    surovatamig [INN]
    B-Cell Non-Hodgkin Lymphoma$AZN ASTRAZENECA PLC
  • Phase 2
    surufatinib
    surufatinib
    Solid Tumor$HCM HUTCHMED (China) Ltd
  • Phase 3
    survodutide
    survodutide
    Liver Fibrosis Boehringer Ingelheim International GmbH
  • Phase 2
    surzebiclimab
    surzebiclimab
    Recurrent Head And Neck Squamous Cell Carcinoma$ONC BeOne Medicines Ltd.
  • Phase 2
    sutacimig
    sutacimig [INN]
    Bleeding And Clotting Disorders Hemab ApS
  • Marketed
    sutimlimab
    Enjaymo (sutimlimab-jome)
    Acquired (Autoimmune) Hemolytic Anemia Bioverativ Inc
  • Marketed
    suvorexant
    Belsomra (suvorexant)
    Insomnia$MRK Merck & Co., Inc.
  • Phase 2
    suvratoxumab
    suvratoxumab
    Staphylococcus aureus Infections Aridis Pharmaceuticals Inc
  • Phase 3
    tadekinig alfa
    tadekinig alfa [INN]
    Hemophagocytic Lymphohistiocytosis AB2 Bio Ltd
  • Marketed
    tafamidis
    Vyndamax (tafamidis)
    Familial Amyloid Cardiomyopathy$PFE PFIZER INC
  • Phase 3
    tafasitamab
    Monjuvi (tafasitamab)
    Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…$INCY INCYTE CORP